Philips initiates trial to test X-ray dose technology for CAD
Philips has initiated the RADIQAL trial to assess its new ultra-low X-ray dose technology in treating coronary artery disease (CAD). The post Philips initiates trial to test X-ray dose technology for CAD appeared first on Medical Device Network.

The post Philips initiates trial to test X-ray dose technology for CAD appeared first on Medical Device Network.